| 前收市價 | 5,142.00 |
| 開市 | 5,100.00 |
| 買盤 | 5,156.00 x 0 |
| 賣出價 | 5,167.00 x 0 |
| 今日波幅 | 5,087.00 - 5,167.00 |
| 52 週波幅 | 3,767.00 - 6,697.00 |
| 成交量 | |
| 平均成交量 | 2,315,125 |
| 市值 | 8.485T |
| Beta 值 (5 年，每月) | 0.51 |
| 市盈率 (最近 12 個月) | 25.97 |
| 每股盈利 (最近 12 個月) | 198.54 |
| 業績公佈日 | 2024年7月25日 |
| 遠期股息及收益率 | 82.00 (1.59%) |
| 除息日 | 2024年6月27日 |
| 1 年預測目標價 | 6,031.80 |
ZacksChugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
After losing some value lately, a hammer chart pattern has been formed for Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
ZacksChugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) Upgraded to Buy: Here's Why
Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (CHGCY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
